New 2024 A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT) Group Pharmacist Committee 1st listed author Vera Domingos Journal Bone Marrow Transplant.
New 2024 Autologous stem cell transplantation in T-cell/histiocyte-rich large B-cell lymphoma: EBMT Lymphoma Working Party study Group Lymphoma Working Party (LWP) 1st listed author Simon Renders Journal Blood Adv.
New 2024 Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide-based graft-versus-host disease prophylaxis than with double unit umbilical cord blood in patients with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Frédéric Baron Journal Am J Hematol.
New 2024 Haematopoietic stem cell transplantation for CTLA-4 insufficiency across Europe: an EBMT Inborn Errors Working Party study Group Inborn Errors Working Party (IEWP) 1st listed author Christo Tsilifis Journal J Allergy Clin Immunol.
New 2024 High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT Group Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author S Secondino Journal ESMO Open.
New 2024 Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT Group Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author Urban Novak Journal Bone Marrow Transplant.
New 2024 Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study Group Acute Leukemia Working Party (ALWP) Other society 1st listed author Dietger Niederwieser Journal Haematologica.
New 2024 Trends in allogeneic transplantation for favorable risk acute myeloid leukemia in first remission: a longitudinal study of >15 years from the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.
New 2024 Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Rama Al Hamed Journal Bone Marrow Transplant.
New 2024 Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies Group Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author Esteban Arrieta-Bolaños Journal J Clin Oncol.
New 2024 Allogeneic Hematopoietic Stem Cell Transplantation in Immunodeficiency-Centromeric Instability-Facial Dysmorphism (ICF) Syndrome: an EBMT/ESID Inborn Errors Working Party Study Group Inborn Errors Working Party (IEWP) Other society 1st listed author Dagmar Berghuis Journal J Clin Immunol.
New 2024 Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Razan Mohty Journal Bone Marrow Transplant.